 |
|
In vitro and in vivo pharmacokinetic characterization of LMT-28 as a novel small molecular interleukin-6 inhibitor
Sung-Hoon Ahn (Ahn SH), Tae-Hwe Heo (Heo TH), Hyun-Sik Jun (Jun HS), Yongseok Choi (Choi Y)
Asian-Australas J Anim Sci. 2020;33(4):670-677. Published online 2019 Aug 3 DOI: https://doi.org/10.5713/ajas.19.0463
|
|
Citations to this article as recorded by
 Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs
Akey Krishna Swaroop, Preeya Negi, Ayushi Kar, Esakkimuthukumar Mariappan, Jawahar Natarajan, Krishnan Namboori P.K., Jubie Selvaraj
Cytokine & Growth Factor Reviews.2024; 76: 48. CrossRef Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective
Dipesh S. Harmalkar, Aneesh Sivaraman, Hossam Nada, Joohan Lee, Hyeseul Kang, Yongseok Choi, Kyeong Lee
Medicinal Research Reviews.2024;[Epub] CrossRef Folic acid deficiency exacerbates the inflammatory response of astrocytes after ischemia‐reperfusion by enhancing the interaction between IL‐6 and JAK‐1/pSTAT3
Man Cheng, Xiaoshan Liang, Linran Shi, Qiang Zhang, Liwen Zhang, Zhongying Gong, Suhui Luo, Xuan Wang, Xumei Zhang
CNS Neuroscience & Therapeutics.2023; 29(6): 1537. CrossRef The role of inflammation in autoimmune disease: a therapeutic target
Yu Xiang, Mingxue Zhang, Die Jiang, Qian Su, Jianyou Shi
Frontiers in Immunology.2023;[Epub] CrossRef Antibody-Mediated Screening of Peptide Inhibitors for Monoamine Oxidase-B (MAO-B) from an Autodisplayed FV Library
Jeong Soo Sung, Ji-Hong Bong, Tae Gyeong Yun, Yeonju Han, Yusun Park, Jaeyong Jung, Soo Jeong Lee, Min-Jung Kang, Joachim Jose, Misu Lee, Jae-Chul Pyun
Bioconjugate Chemistry.2022; 33(6): 1166. CrossRef Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes
Jiamin Zheng, Dongdong Chen, Jie Xu, Xiao Ding, Yao Wu, Hong C. Shen, Xuefei Tan
Bioorganic & Medicinal Chemistry Letters.2021; 48: 128229. CrossRef
|